Latest articles on Pharmaceuticals

Britain sets out plans for ‘no-deal’ Brexit

Document details contingency planning if Britain leaves the European Union in March with no transition deal

Antidepressant pollutants make courting birds violent — study

Male starlings sang less and were more aggressive towards females that had been given small doses of the antidepressant Fluoxetine

Fighting the spread of fake drugs in Africa

The battle to eliminate fake pharmaceutical products is being stepped up

National cancer drug shortage may last until October

Pharmaceutical companies say that delayed drug registrations by the Medicines Control Council may have played a role in stock outs.

Money can’t be the only motive for developing life-saving medicines

Will the world act now to be ready for the next big outbreak?

Activists lead fight for the right to cheaper drugs

There is a big move afoot to alert SADC members to the concessions on intellectual property rights that they can take advantage of.

TB drug priced out of reach

A promising new TB drug is now on the market but doctors say it's been priced out of reach.

Activists fear a pharmaceutical plot is at play

The department of trade and industry has yet to finalise patent reforms, raising questions that cheaper medication could be blocked intentionally.

New drug policy is patently high risk

There is widespread support for drastic change to patent laws when it comes to pharmaceuticals, but the results could be disastrous.

Letters to the editor: January 24 to 30 2014

M&G readers comment on comparisons of Nelson Mandela, Thabo Mbeki and Jacob Zuma, and say we need cool heads when it comes to pharmaceutical drugs.

Editorial: Stop the rot of secret party funding

We should welcome the arrival of US-style political lobbying in South Africa, done in public rather than in private.

Motsoaledi: Big pharma’s ‘satanic’ plot is genocide

Health minister Aaron Motsoaledi is livid about a pharmaceutical company campaign he says will restrict access to crucial drugs.

PIC still mulling Adcock’s $1.3bn CFR deal

The pharmaceutical company Adcock's biggest shareholder PIC says it has not yet made a decision about whether to support the takeover of CFR.

Battle on the horizon over intellectual property policy draft

Some have lauded the draft policy, saying it could make medication cheaper, but others say it is "unimpressive" and "almost contradictory".

New policy gives generic medicines the upper hand

A draft intellectual property policy has been lauded by rights groups who say its repercussions on drug patents could make medicines more affordable.

vital information

The Mail & Guardian’s essential coverage of the ongoing coronavirus crisis is free to read for everyone.

If you would like to support us, please consider taking out a subscription.

Latest

Vodacom swindled out of more than R24m worth of Apple iPhones

A former employee allegedly ran an intricate scam to steal 8700 phones from the cellular giant

We will find resources to ensure the Zondo commission completes its work — Lamola

Justice Minister Ronald Lamola says his department will ensure the state capture commission is afforded the financial resources to complete its work, despite the treasury’s uncertainty

Tobacco industry calls Dlamini-Zuma’s bid to appeal ban a costly folly

The minister could spend the state’s money on fighting Covid-19 and cigarette cartels, tobacco manufacturers argue

Press Releases